| Indication | Treatment |
| Primary prophylaxis | |
| Any surgery | Unfractionated heparin subcutaneously 5000 IU three times daily |
| Malignancy or orthopaedic surgery | Unfractionated heparin subcutaneously 5000 IU three times daily, possibly with replacement of deficient factors |
| Pregnancy | Unfractionated heparin subcutaneously 5000 IU three times daily |
| Pregnancy in antithrombin III deficiency | Therapeutic dose of unfractionated heparin to prolong APTT or dose adjusted warfarin (INR 2.0-3.0), except during first trimester and latter part of third trimester, when unfractionated heparin is used |
| Puerperium (for 4-6 weeks) | Unfractionated heparin subcutaneously 5000 IU three times daily or dose adjusted warfarin (INR 2.0-3.0) |
| Secondary prophylaxis | |
| First episode of thrombosis | Dose adjusted warfarin for 6 months |
| First episode of life threatening thrombosis, multiple deficiencies, continuing predisposing factor | Lifelong oral anticoagulation |
| Recurrent thrombosis | Lifelong oral anticoagulation |
| Treatment of established thrombosis | |
| Treatment of acute thrombosis | Unfractionated heparin to prolong APTT followed by oral anticoagulation treatment, possibly with replacement of the deficient factors |